More articles about: Clinical Trials

University of Michigan Health has launched a brain-computer interface clinic for patients with motor and speech disabilities. The advanced technology has potential to recover functionality loss that occurs due to injury or disease.

Huntington disease research can be challenging as it is difficult for patients to get to clinical research sites. This new device brings the research mechanisms to them with the ability to complete studies from home.

The CAR-T treatment has been used in cancer patients for years. Now the approach is being used for those with severe scleroderma to teach the body to fight the autoimmune disorder.

Brain and spinal cord tumors account for one in four childhood cancers. Although 75% of children survive for at least five years after being diagnosed, many patients have recurrent tumors that cannot be cured. Andrea Franson discusses current therapies for pediatric brain tumors, how viruses can be used to target tumor cells and the new phase 1 trial that started in May 2025.

Federal grants awarded to University of Michigan researchers help to drive innovation and economic growth, supporting thousands of jobs and generating millions in research-related spending across the United States. 

Michigan Medicine experts discuss CAR T therapy, its use in other clinical trials at U-M and the new Phase I trials that started in March 2025.

In the United States, unnecessary tests and treatments not only drive-up health care costs but may also contribute to a waste of valuable resources and avoidable patient harms. Today we talk with Michigan Medicine assistant professor of surgery Dr. Lesly Dossett, M.D., MPH about an effort to reduce such practices through a process called de-implementation.

Here, Monalisa Ghosh, M.D., a hematologist-oncologist at the University of Michigan Health Rogel Cancer Center, answers questions about cellular therapy; how it's used and what exciting developments are soon to come.

The availability of clinical trials of new treatments for cancer varies greatly by geography, and a new study shows more socially vulnerable areas have far fewer.

Today on The Fundamentals is Dr. Kevin Boehnke, research assistant professor in the Department of Anesthesiology and the Chronic Pain and Fatigue Research Center. His current research focuses on therapeutic applications of cannabis and psychedelics. His goal is to rigorously assess appropriate use of these substances and to help address the public health harms caused by their criminalization.

Patient at Michigan Medicine finds treatment for venous disease, which drastically changes his life.

Researchers hope it will improve diagnosis and treatment, as well as clinical trial enrollment.

The year provided one fascinating research story after another.

Trial will evaluate the safety and efficacy of histotripsy against liver tumors at eight U.S. sites

Studies suggest the gut microbiome can influence immunotherapy side effects. Butyrate emerges as an intriguing candidate against inflammation in the colon.